Search filters

Filters
Clear All

Phase

  • 182
  • 151
  • 2
  • 188
  • 147
  • 17
  • 373
  • 1196
  • 568
  • 28
  • 44
  • 2
  • 1128
  • 1197
  • 5

Found 1202 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

99 years or below
All genders
1. To determine the feasibility of integrating a PGx panel test in the EMR with a pharmacist PGx e-consult. 2. Determine the fidelity to genotype-guided pharmacotherapy recommendations. 3. To determine if PGx testing will improve the patient self-reported numeric pain scores 4. To determine if PGx testing will reduce MME …
99 years or below
All genders
The LuxDx Perform study is a prospective, multicenter, single arm post market observational study. Patient indicated to be implanted with the LUX-Dx ICM for one of the ff. reasons cryptogenic stroke, syncope, AF management, post AF ablation or suspected AF will be enrolled in this study. Lux Dx ICM is …
99 years or below
All genders
This randomized clinical trial will evaluate the effect of tonabersat compared with placebo on central subfield thickness (CST) in eyes with center-involved DME and good visual acuity.
99 years or below
All genders
Phase 3
The primary safety objective is a composite of the number of Major Adverse Events (MAEs) occurring through 30 days post-procedure compared to the rate in subjects treated with the Relay Thoracic Stent-Graft in the U.S. Pivotal Trial (P110038). The primary effectiveness objective is a composite of the number of effectiveness …
99 years or below
All genders
This study has a mono therapy arm and a combination therapy arm. The main purpose of the mono therapy arm is to test the safety and tolerability of ART4215 in humans. The main purpose of the combination therapy arm is to test ART4215 compared to and in combination with talazoparib.
99 years or below
All genders
he purpose of this expanded access program (EAP) is to provide ciltacabtagene autoleucel (cilta-cel) that does not meet the commercial release specifications of CARVYKTI and is not available via the local health care system in the country where the treatment is requested.
99 years or below
All genders
Phase 2
Please refer to Protocol Section 4 Please refer to Protocol Section 4 Please refer to Protocol Section 4
99 years or below
All genders
Please refer to Protocol Section 3.0. Please refer to Protocol Section 3.1. Please refer to Protocol Section 3.2.
 Effects of psychiatric medications on decision-making study
18 years - 45 years
All genders
This study involves taking single doses of two common psychiatric medications – levodopa (Sinemet) and escitalopram (Lexapro) – and doing a few decision-making tasks. The purpose of the study is to understand how two chemicals in the brain, dopamine and serotonin, are involved in decision-making. This is not a form of …
99 years or below
All genders
Phase 3
To evaluate the effectiveness of 4-mg baricitinib in significant increase in hair regrowth in patients with severe AA To describe the effectiveness of 4-mg baricitinib in achieving regrowth as assessed by physician assessed signs and symptoms of AA Mean percentage change from baseline to Week 52 in SALT score. Proportion …
601 - 610 of 1202